Facebook
Twitter
LinkedIn
Forward
9th Annual Updates from ASH 2023: Practice-Changing Abstracts
Chicago, IL US
March 1, 2024
Elevate Your Impact in Hematologic Oncology!
Join us for this not-to-miss event that brings together community-based providers and esteemed academic oncologists. Together, we will improve patient care and outcomes in hematologic malignancies.
Our mission is clear: To save lives. We're committed to achieving this by exploring cutting-edge treatment options and harnessing medical breakthroughs that will significantly reduce cancer-related fatalities. This includes delving into groundbreaking approaches like CAR T-cell therapy, innovative immunotherapies, and precision-targeted agents.
This activity will help healthcare professionals redefine the standard of care for both newly diagnosed patients and those facing relapsed blood cancers. It will empower them to stay at the forefront of their field by providing them with the latest scientific advancements, inspiring innovative ideas, and addressing the most pressing issues concerning patients afflicted with these diseases.
Together, let's make a real difference in the lives of those battling hematologic malignancies. Join us in shaping the future of hematologic oncology.
Learn more at the conference website!
Target Audience
This activity is designed for hematologists, medical oncologists, pathologists, fellow and resident trainees, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals dedicated to treating hematologic cancers.
Learning Objectives
After this activity, participants will be able to:
- Recall the optimal patient selection, timing, and regimens for stem cell transplantation;
- Recognize the optimal sequencing of novel therapeutic options in the care of lymphoma patients with the incorporation of recent advancements in the field;
- Identify available clinical trial options and other approaches to patients with relapsed/refractory disease;
- State the role of existing and emerging targeted agents in leukemias and myeloid neoplasms;
- Discuss how to appropriately sequence treatment in multiple myeloma, from the use of frontline multi-drug combinations to the role of CAR T and bispecific antibodies in relapsed/refractory disease;
- Illustrate how cutting-edge data presented at the 2023 Annual Meeting of the American Society of Hematology can apply to clinical practice;
- Explain how to diagnose and treat common benign hematologic diseases with newly approved therapies;
- Interpret emerging clinical trial data in the context of CAR T-cell therapy for lymphoid malignancies.
Pre-Conference
Time | Description | Moderators / Speakers |
|---|---|---|
| 8:00AM | Conference Registration Open / Breakfast open / Meet & Greet (in-person only) | |
| 8:30AM | Fellows Meet the Expert (in-person only) | Noopur Raje, MD |
| 9:00AM | Updates in Hematological Pharmacology | Jennifer Collins, PharmD, BCOP, Emily Dworkin, PharmD, BCOP, Kaitlin Kelly, PharmD, BCOP |
| 9:30AM | Concurrent Sessions: (A) Fellows: Case Based Clinical Trial Considerations (B) Allied Health / Nursing Session *MOC Credit not available for this nursing session | (A) Rafael Madero Marroquin, MD, Alexandra Rojek, MD, Joseph Cannova, MD (B) Mylove Mortel, MSPH, RN, OCN Andrea Fadel, BSN, RN, OCN, Rebecca Malloy, BSN, Asta Siugzdinis, BSN |
| 10:30AM | Break, Visit Exhibits, Networking |
Main Conference
Time | Session Title | Moderators | Speakers |
|---|---|---|---|
| 11:00AM | Keynote: Myeloma | Sonali Smith, MD | Noopur Raje, MD |
| 12:00PM | Lunch, Visit Exhibits, Networking | ||
| 1:00PM | HL & NHL | Justin Kline, MD | Sonali Smith, MD |
| 1:30PM | Break, Visit Exhibits, Networking | ||
| 1:45PM | Updates in Myelofibrosis, MPN, MDS | Olatoyosi Odenike, MD | Satya Kosuri, MD |
| 2:15PM | Updates in AML | Olatoyosi Odenike, MD | Anand Patel, MD |
| 2:45PM | Break, Visit Exhibits, Networking | ||
| 3:00PM | Panel: CLL | Sonali Smith, MD | Michael Thirman, MD, Peter Riedell, MD, Justin Kline, MD |
| 3:30PM | Updates in Myeloma | Olatoyosi Odenike, MD | Benjamin Derman, MD |
| 4:00PM | Updates in Transplantation | Olatoyosi Odenike, MD | Adam DuVall, MD, MPH |
| 4:25PM | Updates in cellular therapy/ non-cell therapy for Acute Leukemias (AML/ALL) | Satya Kosuri, MD | Mariam Nawas, MDD |
| 4:50PM | Closing Remarks | Satya Kosuri, MD | Michael Bishop, MD |
| 5:00PM | Adjourn/Reception |
The agenda is subject to change.
Convene
333 N Green Street
Chicago, IL
60607
United States
HYBRID CONFERENCE
Participants can participate in person or virtually. For more information, contact Meeting Achievements via e-mail.
CONVENE
Convene at 333 North Green Street offers over 40,000 square feet of purpose-built meeting and event space for small to large programs. This property includes a dedicated meetings and events floor, sweeping views of downtown, optimal branding opportunities, and a unique design. The state-of-the-art meeting space is fully outfitted with seamless technology, an onsite AV team, and 5-star hospitality that will elevate your next meeting and event experience. Learn more at their website.
WANT TO KNOW MORE?
Learn more about the conference by visiting the conference website!VISITING CHICAGO
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic sixth year in a row. To help plan your stay in Chicago, visit choosechicago.com.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via email at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTOR
Michael R. Bishop, MDProfessor of Medicine
Director, Jonas Center for Cellular Therapy
Director, Hematopoietic Stem Cell Transplantation Program
KEYNOTE FACULTY
Noopur Raje, MDProfessor, Medicine
Director, Multiple Myeloma Program, Medical Oncology
Harvard University
UNIVERSITY OF CHICAGO PLANNING COMMITTEE
| Andrzej Jakubowiak, MD, PhD Professor of Medicine Director, Myeloma Program | Justin Kline, MD Associate Professor of Medicine Director, Lymphoma Program |
Rafael Madero Marroquin, MD Fellow, Hematology and Medical Oncology | Mylove Mortel, MSPH, RN, OCN Assistant Director, Transplant & Cell Therapy Clinical Operations |
Toyosi Odenike, MD Professor of Medicine Director, Leukemia Program | Alexandra Rojek, MD Fellow, Hematology and Medical Oncology |
Sonali Smith, MD Elwood V. Jensen Professor in Medicine Chief, Sections of Hematology/Oncology |
UNIVERSITY OF CHICAGO FACULTY
Kenneth Cohen, MD Assistant Professor of Medicine | Mariam Nawas, MD Assistant Professor of Medicine |
| Benjamin A. Derman, MD Assistant Professor of Medicine | Peter A. Riedell, MD Assistant Professor of Medicine |
Satyajit Kosuri, MD Assistant Professor of Medicine | Michael Thirman, MD Associate Professor of Medicine |
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 6.25 contact hours.
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Pediatrics MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES ARE AVAILABLE! SPACE IS LIMITED, SO SIGN UP TODAY!
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide opportunities for organizations to advertise their products and services to conference participants. Whether you are sharing information about your company's products, connecting with physicians during one of the scheduled breaks, or gaining brand recognition for your company through program acknowledgments, your message will reach physicians, hematologists, pathologists, medical oncologists, trainees, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals dedicated to the treatment of hematologic cancers.
Download the prospectus 
here or contact Meeting Achievements at [email protected] or (219) 465-1115. We hope to see you there!
here or contact Meeting Achievements at [email protected] or (219) 465-1115. We hope to see you there!
REGISTRATION
Early rates expire on December 27, so reserve your spot today!
Profession Type | In Person | Virtual |
|---|---|---|
Physicians | $100/$125 | $50/$60 |
Nurses, Pharmacists, Other Healthcare Professionals | $45/$60 | $30/$40 |
Residents & Fellows with a verification letter | $25 | $25 |
| UChicago Faculty & Staff | $25 | $0 |
| Industry | $495 | $195 |
CANCELLATION POLICY Please see the registration site for the full details. | ||
JOINING THE VIRTUAL CONFERENCE
You will receive login information from Meeting Achievements via the e-mail address used at registration 48 hours before the conference. Onsite/Day of registrants, please allow 10-15 minutes post-registration for access information to be generated.
If you need assistance joining the session or experience other technical issues, contact technical support.
If you need assistance joining the session or experience other technical issues, contact technical support.
CLAIMING CREDIT
After creating an account or logging in, enter the access code to unlock the credit claiming process.
Please Note: The credit claiming process will close three months after the activity ends. Requests to claim credit after three months will be subject to additional fees.
Please login or create an account to proceed.